英文别名 |
1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one;2OYE00PC25;PF06651600;ritlecitinib (proposed INN);GTPL9559;BCP24778;example 5 [WO2015083028];DB14924;compound 11 [PMID: 28139931];S8538;PF06651600;PF 06651600;1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one malonate;1-[(2S,5R)-2-methyl-5-;Ritlecitinib;EX-A2613;compound 11 (PMID: 28139931);RITLECITINIB [INN];1-[(2S,5R)-2-methyl-5-{7H-pyrrolo[2,3-d]pyrimidin-4-ylamino}piperidin-1-yl]prop-2-en-1-one;1-((2S,5R)-2-methyl-5-((7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one;1-[(2S,5R)-2-methyl-5-({7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)piperidin-1-yl]prop-2-en-1-one;SCHEMBL24377696;AC-35550;MS-24066;Ritlecitinib?;CHEBI:229233;UNII-2OYE00PC25;PF 06651600;CHEMBL4085457;CS-0020243;PF-06651600;RITLECITINIB [WHO-DD];PF-06651600 free base;1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one;1792180-81-4;1-((2S,5R)-2-methyl-5-(7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)piperidin-1-yl)prop-2-en-1-one;example 5 (WO2015083028);C91239;ritlecitinibum;RITLECITINIB (PF-06651600);1-(5-((7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one;C15H19N5O;HY-100754;2-PROPEN-1-ONE, 1-((2S,5R)-2-METHYL-5-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-1-PIPERIDINYL)-;SCHEMBL16764638;BP168506;CCG-267324;AKOS040758742;JAK3 Inhibitor PF-06651600;DB-179694;2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]- |